Patient guide · Reviewed May 2026
Liver Fibrosis Test Options in Australia — A Complete Guide
Liver fibrosis — scarring of the liver — is the most important factor in determining prognosis for patients with MASLD and other chronic liver diseases. Detecting and staging fibrosis accurately is critical for making treatment decisions. Several tests are available in Australia, ranging from a simple blood calculation to specialist imaging.
This guide explains each option, what it measures, and when it is appropriate.
Published 2026-05-31 · Clinically reviewed 2026-05-31
Patient guide · Reviewed May 2026
Why Fibrosis Testing Matters
Liver fibrosis progresses through five stages — F0 (no scarring) to F4 (cirrhosis). The stage of fibrosis at diagnosis is the strongest predictor of long-term…
Liver fibrosis progresses through five stages — F0 (no scarring) to F4 (cirrhosis). The stage of fibrosis at diagnosis is the strongest predictor of long-term liver outcomes including cirrhosis, liver cancer, and liver failure.
Most patients with early fibrosis (F0–F1) have normal life expectancy and can be managed with lifestyle modification. Patients with F2–F3 fibrosis need active monitoring and may benefit from pharmacological treatment including semaglutide (Wegovy) under Australia's April 2026 TGA approval. F4 (cirrhosis) requires specialist management and regular cancer surveillance.
Because fibrosis is almost always asymptomatic until advanced stages, testing at-risk populations before symptoms develop is essential.
Test 1 — FIB-4 Score (First Line, Blood Test)
The FIB-4 score is the recommended first-line fibrosis assessment in Australian clinical guidelines. It requires no additional testing beyond a standard blood panel.
How it works: FIB-4 = (Age × AST) ÷ (Platelets × √ALT). Your GP calculates this from results already on your blood test.
Results:
- Below 1.3: Low risk of significant fibrosis — repeat in 3 years
- 1.3–2.67: Indeterminate — proceed to elastography
- Above 2.67: High risk — refer to hepatologist
Cost: No additional cost — uses existing blood test results.
Limitation: The FIB-4 is a risk stratification tool, not a diagnostic test. The indeterminate range (1.3–2.67) affects most patients with MASLD — which is why elastography is needed as a second step for this group.
Patient guide · Reviewed May 2026
Test 2 — Transient Elastography (FibroScan/iLivTouch)
The recommended second-line test for patients with an indeterminate FIB-4. See the full guide at /patientcare/transient-elastography-explained.
The recommended second-line test for patients with an indeterminate FIB-4. See the full guide at /patientcare/transient-elastography-explained.
How it works: Measures liver stiffness (kPa) and fat content (CAP/UAP score) using a mechanical pulse through the skin.
Results: kPa below 8 = reassuring. 8–13 = moderate to significant fibrosis. Above 13 = cirrhosis range.
Cost: $150–$300 privately. No Medicare rebate currently for most MASLD indications.
Availability: Widely available across Australian cities. Some clinics accept self-referred patients.
Test 3 — Enhanced Liver Fibrosis Panel (ELF Test)
The ELF test is a blood test measuring three direct markers of liver fibrosis: hyaluronic acid, PIIINP (a collagen precursor), and TIMP-1 (a tissue inhibitor of metalloproteinase). Unlike FIB-4, which uses indirect markers, ELF measures proteins directly involved in the fibrosis process.
How it works: Standard blood draw sent to a reference laboratory. Results available within days.
Results: ELF score below 7.7 = low risk. 7.7–9.8 = moderate risk. Above 9.8 = high risk of advanced fibrosis.
Availability: Available at some specialist hepatology centres and private pathology labs in Australia. Not yet widely used in primary care. Discuss with your hepatologist or gastroenterologist.
Cost: Approximately $50–$150 depending on laboratory.
Patient guide · Reviewed May 2026
Test 4 — 2D Shear Wave Elastography
Specialist imaging centre test using high-end ultrasound machines to measure liver stiffness with a colour-coded stiffness map. More comprehensive imaging than…
Specialist imaging centre test using high-end ultrasound machines to measure liver stiffness with a colour-coded stiffness map. More comprehensive imaging than FibroScan but requires specialist equipment.
See /patientcare/fibroscan-vs-alternatives for full comparison.
Test 5 — MRI Elastography
The most accurate non-invasive fibrosis assessment available — measures stiffness across the entire liver volume. Reserved for complex cases where other tests are inconclusive.
Cost: $500–$900+. Limited availability at specialist centres.
Patient guide · Reviewed May 2026
Test 6 — Liver Biopsy
The diagnostic gold standard. Definitive fibrosis staging and MASH diagnosis. Reserved for cases where non-invasive tests are inconclusive and management…
The diagnostic gold standard. Definitive fibrosis staging and MASH diagnosis. Reserved for cases where non-invasive tests are inconclusive and management decisions require certainty.
Cost: $1,500–$3,000+. Requires hospital or day procedure admission.
The Recommended Australian Pathway
This pathway is recommended in the MJA September 2025 consensus statement and the 2026 Australian Prescriber MASLD update:
- At-risk patient (T2D, obesity, elevated liver enzymes, GLP-1 medication)
- Step 1: FIB-4 score from routine blood panel (GP)
- FIB-4 below 1.3 → Reassure. Repeat in 3 years.
- FIB-4 1.3–2.67 → Liver elastography (FibroScan/guided)
- FIB-4 above 2.67 → Hepatologist referral recommended
- Elastography result
- kPa below 8 → Reassure. Monitor. Annual LFTs.
- kPa 8–13 → Specialist review. Consider treatment.
- kPa above 13 → Urgent specialist referral
Find a liver elastography clinic near you
Search by suburb or postcode to see accredited clinics offering FibroScan and guided liver elastography across Australia.
Type a suburb or postcode and press Enter to search nearby.
Request a liver scan appointment
Submit your details and we'll route your request to the most appropriate elastography clinic in your area. Most clinics respond within 1–2 business days.
Take action
Request an appointment
Frequently asked questions
What is the most accurate test for liver fibrosis in Australia?
Liver biopsy remains the gold standard but is invasive. For non-invasive testing, MRI elastography is most accurate but least accessible. For most patients, the FIB-4 → transient elastography pathway provides sufficient accuracy for clinical decision-making at a practical cost and access level.
Can my GP arrange liver fibrosis testing?
Yes. Your GP can calculate your FIB-4 score from your routine blood panel and refer for elastography if needed. Some GPs also have access to FibroScan or guided elastography in their practice. Ask your GP specifically about liver fibrosis testing at your next appointment.
Is the ELF test available in Australia?
The ELF test is available at some specialist centres and private pathology laboratories. It is not yet part of the standard GP referral pathway but is used by hepatologists in complex cases.
How often should I have fibrosis testing?
If your FIB-4 is low risk (below 1.3), repeat in 3 years. If elastography shows F0–F1, annual liver function tests with elastography every 2–3 years. If F2 or above, your hepatologist will advise the appropriate monitoring interval — typically annual elastography.
This article is for educational purposes only. It does not constitute medical advice. Always consult your GP or a specialist about your individual health circumstances.
Next step
Find a liver elastography clinic near you
Search participating clinics across Australia, or submit an appointment request and we will route you to the nearest available provider.